Normal
25th and 26th May 2022

7th Annual MarketsandMarkets High Potent Medicines Conference [Time zone - (British Summer Time)]

Renaissance London Heathrow Hotel - Marriott

One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations. 

Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. Globally, there is a significant growth in the incidence of cancer. Diseases like musculoskeletal diseases, glaucoma, and specifically cancer have a significant impact on the health status of people worldwide, with comparatively higher growth rates in developing countries.

The 7th Annual MarketsandMarkets High Potent Medicines Conference to be held on 25th -26 th May 2022. This conference would address the challenges in continual evolution of industry standards, technologies, and regulations. Leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.

WHAT TO EXPECT

Key Highlights

  • Process Development and scale up of HPAPI’s
  • Strategies for effective outsourcing partnership
  • Containment and Handling Strategies
  • Validation of cleaning procedures to avoid cross contamination
  • Regulatory Landscape
  • Hazard Assessment Classifications

Why Attend?

  • Utilizing the best practices to ensure safe and efficient production of high potent medicines
  • Training sessions on complex high potent compounds handling and containment issues
  • Understanding the updated regulatory guidelines in the HPAPI process
  • Implementing response plans to react to an unplanned event
  • Knowing the outsourcing strategies to effectively build a reliable supply chain

Who Should Attend?

From pharmaceutical and Biopharmaceutical manufacturing:

Chief executives, VP’s, Directors, Heads, Leaders, Senior Managers, Principal Scientists, Principal Toxicologists, Toxicologists, Fellows, Investigators working in:

  • Research & Development
  • Manufacturing/Operations/Production
  • Maintenance
  • Engineering
  • Risk Assessments
  • Laboratory Services/Analytical
  • New Technologies
  • Process Development/Technical transfer

CONFERENCE AGENDA

Registration

08:15 - 09:00

Welcome note from MarketsandMarkets

09:00 - 09:05

Opening Remarks from the Chairman

09:05 - 09:10 Fred Ohsiek , Senior Validation Manager, Ecolab
Session 1: Process Development and Scale up

Keynote Presentation- Key considerations when choosing the right CDMO for the development and manufacturing of drug products containing HPAPI

09:10 - 09:50 David O Connell , Director, Scientific Affairs, PCI Services, UK

Past, Present and Future of HPAPI Production- Olon Global Integrated Platform

09:50 - 10:30 Paola Devoti, Corporate Project Engineering, Olon Spa, Italy

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:30 - 11:15

Risk considerations for the contract manufacturing for of HPAPIs

11:15 - 11:55 Anna Kuleza, Director CMC Pharmaceutical Development, Clovis Oncology, Switzerland

HPAPI milling and micronization contained system

11:55 - 12:35 Stefano Butti , Sales Director, Food Pharma Systems, Italy

Manufacturing of Oncological Products

12:35 - 13:15 Fabio Zenobi, EHS Director, BSP Pharmaceuticals, Italy

Lunch and Poster Presentation | One-to-One Networking Meetings

13:15 - 14:15

Does your CMO have what it takes to handle HPAPI’s?

14:15 - 14:55 Richard Arnette, Manager, Industrial Hygiene and Toxicology, Pharmascience, Canada
Session 2: Containment & Handling

Ultra-potent pharmaceuticals: verifying containment

14:55 - 15:35 Martin Axon, Senior Principal Occupational Hygienist , SafeBridge Europe

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:35 - 16:25

How to handle HPAPIs within Chemical Development (case studies)

16:25 - 17:05 Thomas Adam, Head of Global Quality Assurance Chemical APIs, , Bayer, Germany

Closing Remarks from the Chairman

17:05 - 17:10

Drinks Reception & Networking

17:10 - 17:10

End of Day 1

17:10 - 17:10
Enquire Now

Sponsor/Exhibit Delegate
CONFERENCE SPEAKERS
Speakers
Fabio Zenobi
Fabio Zenobi
EHS Director, BSP Pharmaceuticals, Italy
Stefano Butti
Stefano Butti
Sales Director, Food Pharma Systems, Italy
Thomas Adam
Thomas Adam
Head of Global Quality Assurance Chemical APIs, , Bayer, Germany
Paola Devoti
Paola Devoti
Corporate Project Engineering, Olon Spa, Italy
Kenneth Farrugia
Kenneth Farrugia
Quality Assurance Manager , Natrix Sciences, Malta
Fred Ohsiek
Fred Ohsiek
Senior Validation Manager, Ecolab
Martin Axon
Martin Axon
Senior Principal Occupational Hygienist , SafeBridge Europe
William Hawkins
William Hawkins
Managing Toxicologist, SafeBridge Europe
Please contact [email protected] for speaking opportunity
SPONSORS
Gold
example-image

FPS

Silver
example-image

PCI Pharma Services

Speaking Partner
example-image

BSP Pharmaceuticals

example-image

Olon

Meeting Partner
example-image

Skyepharma

PARTNERS
Media Partners
example-image

Bentham Science

LOCATION
Renaissance London Heathrow Hotel - Marriott
About the Hotel

Bath Road | Hounslow | Middlesex TW6 2AQ

PAST EVENT GALLERY
  • Networking-Room
  • Networking-Event
  • Networking-Exhibition-Audience
  • Networking-Exhibition
  • Discussion-Conference-Audience
  • Conference-Speaker
  • Conference-Audience-Discussion
  • Conference-Room-Audience
  • Conference-Room
  • Conference-Audience
  • High Potent Medicines Conference - Networking area
  • High Potent Medicines Conference - Exhibition Area - Booths